U.S. DEPARTMENT OF JUSTICE A1 FINANCIAL CRIME HIGH RISK Published 6 Oct 2026 at 12:00 UTC, affecting US

DOJ: Former Connecticut Resident Pleads Guilty to Health Care Fraud Charge

DOJ reports Jacqueline Pelphrey pleaded guilty to health care fraud, admitting $1,299,633.10 in losses to Medicaid and other insurers.

Read the original notice ↗ All US items

In short

  • Pelphrey submitted fraudulent claims for custom breast prostheses that clients did not order, purchase, or receive.
  • She is released on a $10,000 bond pending sentencing scheduled for December 29.

What happened

Jacqueline Pelphrey, formerly of Manchester, Connecticut, pleaded guilty in Hartford federal court to health care fraud after waiving her right to be indicted. She owned Women’s Health Resources, which submitted fraudulent claims to Medicaid, private insurers, and other health care benefit programs for custom breast prostheses not ordered or received by clients.

Pelphrey admitted to causing $1,299,633.10 in losses to Medicaid and other health insurance plans. She is currently released on a $10,000 bond, with sentencing set for December 29 in Bridgeport. The investigation was conducted by the U.S. Department of Health and Human Services and the FBI.

FROM THE NOTICE
Pelphrey engaged in a scheme to defraud health care benefit programs, including Medicaid, private insurers, and health care benefit programs for which private insurers processed claims, by submitting fraudulent claims from Women’s Health Resources to the programs for custom breast prostheses that Pelphrey’s clients did not order, purchase, or receive.
DOJ, justice.gov

In numbers

  • $1,299,633.10 Losses to Medicaid and other health insurance plans
  • $10,000 Bond amount
  • 10 years Maximum term of imprisonment for health care fraud

Named in this item

1 entity
STATUS NAME ISO PROGRAM IDENTIFIER
Jacqueline Pelphrey
Person, accused
Screen this name
US — —

What compliance teams should check

  • Review claims submitted by Women’s Health Resources for custom breast prostheses since August 2018.
  • Screen for similar fraudulent claim typologies involving post-mastectomy items and custom prostheses.
  • Monitor entities and individuals named in DOJ and National Fraud Enforcement Division announcements for ongoing investigations.

Why it matters

This case highlights the risks of fraudulent billing schemes targeting Medicaid and private insurers, emphasizing the need for robust controls and monitoring of claims for medical devices and prostheses. Compliance officers should be alert to patterns of claims for items not ordered or received by clients, as such schemes can result in significant financial losses and regulatory scrutiny. The DOJ’s focus on fraud enforcement underscores the importance of proactive detection and reporting of suspicious billing activities.

FOR COMPLIANCE TEAMS

Catch stories like these on your own customers.

complead screens your customers against adverse media, sanctions and PEP lists, and re-checks them every day. When a name you hold turns up in the news, it lands in your case queue with the evidence attached.

Related on the radar

All US items →
16 Oct 2026
FINANCIAL TIMES A2 TERRORISM & SANCTIONS
EU vows to maintain Russia sanctions after US pivot
MED
16 Oct 2026
ABC NEWS (AUSTRALIA) A2 FINANCIAL CRIME
Bonza owner pleads guilty to $500 million fraud
HIGH
16 Oct 2026 MED

How the radar works

Each item is classified by category, pinned to the jurisdictions it affects and scored from 0 to 10. The score starts from a model assessment of how serious the item is, then adds points for the kind of event, what it names and the source behind it. Reliability grades run from A1 (the regulator’s own notice) to C3 (a single secondary source).

AML News Radar reports what its sources publish. Summaries, categories and scores are automated; read the original notice before acting. It is not legal advice and not a screening decision.

Read the full methodology

Subscribe to the radar

You will get new items from every jurisdiction and category.

DIGEST